The Pancreatic Cancer Research Team (PCRT) is a multidisciplined group of preeminent researchers dedicated to organizing and accelerating the clinical development of new agents for the treatment of patients with pancreatic cancer. PCRT's members include laboratory and clinical researchers who share the passion to bring new advances to patients with pancreatic cancer as rapidly as possible; providing the only coordinated effort in the world dedicated to rapidly translating research discoveries into new treatments and supportive care for patients with pancreatic cancer PCRT facilitates Phase I through Phase III clinical trials, with an emphasis on Phase I/II and Phase II trials.

The Pancreatic Cancer Research Team is focused on an all out effort to identify important questions in pancreatic cancer research, to develop novel therapies for the cure of pancreatic cancer, and to design relevant clinical trials to answer these questions.